snapIoT
snapIoT is a private, San Diego-based clinical trial platform founded in 2016 that designs tools to create, launch, and manage clinical trials. The company operates with 11-50 employees and is led by co-founder and CEO Isaac Eteminan.
- Company typePublic
- Founded2016
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What snapIoT does
snapIoT is a privately held, San Diego-based clinical technology company founded in 2016. Per its own short description, snapIoT is "a clinical platform that designs to create, launch, and manage clinical trials." The company operates with 11-50 employees and is led by co-founder, CEO, and board member Isaac Eteminan. No additional product-level detail, technology stack, pricing model, or revenue mechanics are disclosed in the available data.
The business model is not explicitly stated beyond the platform's described function. By inference from the company description, snapIoT likely sells tooling or services to organizations conducting clinical trials (e.g., sponsors, CROs, sites), but the absence of pricing disclosures, named customers, and go-to-market detail means the revenue mechanics — whether SaaS subscription, per-trial fee, or services-led — cannot be confirmed. The aggregated dataset also contains extensive information about Fortrea (a separate, public, large-scale global CRO with 30+ years of history, a proprietary Fortrea Intelligent Technology™ platform, and operations spanning Biopharma/Biotech/MedTech). This Fortrea material appears as data contamination in the snapIoT file and is not used here to characterize snapIoT itself.
The company's competitive positioning is not well-evidenced. Nine years post-founding, snapIoT remains at 11-50 employees with no disclosed funding rounds, partnerships clearly attributable to the company, or named customers. This profile suggests an early-stage or self-funded operation whose commercialization scale is materially below the larger CROs (Fortrea) or venture-backed clinical trial SaaS platforms. Data gaps are significant: no revenue, no ARR, no product roadmap, no AI capabilities disclosure, and a single executive name (Isaac Eteminan) on record.
snapIoT firmographics
Firmographics- Name
- snapIoT
- Legal name
- Fortrea Inc.
- Website
- https://snapiot.com
- Company type
- Public
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- snapIoT is a private, San Diego-based clinical trial platform founded in 2016 that designs tools to create, launch, and manage clinical trials. The company operates with 11-50 employees and is led by co-founder and CEO Isaac Eteminan.
- Ownership category
- akta.pro rank
snapIoT industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where snapIoT is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
snapIoT business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels5 records
snapIoT product offering
Product offeringCore offering
snapIoT is a clinical platform designed to create, launch, and manage clinical trials. The company provides a software platform for organizations conducting clinical research and drug development, supporting workflows associated with the design, initiation, and operational management of clinical studies.
Differentiator
Problem solved
Functional benefit
Brands
- Fortrea Intelligent Technology™: Technology platform enabling faster decision-making and exceptional customer experiences with solutions like FIT Lifecycle Solutions, FIT Foresight Solutions, and FIT Companion Solutions.
Products and services
- snapIoT Clinical Platform
Companies that use snapIoT
Customer profileSegments3 records
Ideal customer profiles1 record
snapIoT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
snapIoT partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SCTbiocoreStrategic collaboration combining Fortrea's clinical development expertise with SCTbio's cGMP manufacturing capabilities for cell-based therapies and viral vectors. The partnership delivers integrated, end-to-end solutions for cell therapy innovators—streamlining timelines, reducing risks, and accelerating delivery of life-changing therapies worldwide.
Scale indicators1 record
Recent moves1 record
Expansion highlights2 records
snapIoT competitors and assessment
Company assessmentDirect peers
- Medidata (Dassault Systèmes): Medidata offers the Rave Clinical Cloud platform for EDC, CTMS, eCOA, and randomization in clinical trials, directly competing with snapIoT's clinical trial management and data capture focus.
- Castor: Castor offers an EDC and eCRF platform for clinical trials, including decentralized trial capabilities, making it a direct competitor to snapIoT in clinical trial data capture and study management.
- Anju Software: Anju Software provides clinical trial management and other life sciences software solutions, including its TrialMaster CTMS and EDC products, competing directly with snapIoT in clinical trial operations.
- ArisGlobal: ArisGlobal provides LifeSphere Clinical Trial technology including CTMS, EDC, and eTMF solutions, directly competing with snapIoT's clinical trial platform focus across biopharma customers.
- Bio-Optronics: Bio-Optronics provides Clinical Conductor CTMS and other clinical trial management solutions, directly competing with snapIoT's clinical trial management focus for sponsors and sites.
- Signant Health: Signant Health provides clinical trial technology solutions including eCOA, IRT, and patient engagement, making it a direct peer in clinical trial platform technology serving similar biopharma sponsors.
- Veeva Systems: Veeva Systems provides Vault CTMS and other clinical trial management solutions to biopharma and CROs, making it a direct competitor to snapIoT's clinical trial platform across the same customer base.
- Clario: Clario provides clinical trial endpoint technology including eCOA, imaging, and respiratory solutions, competing with snapIoT in the clinical trial technology space serving biopharma and CRO customers.
- Calyx: Calyx provides EDC, IRT, and eCOA technology for clinical trials, directly competing with snapIoT in clinical trial data management and patient experience technology.
Broad incumbents
- Oracle Health Sciences (Clinical One): Oracle's Clinical One platform provides unified clinical trial technology as part of its broader life sciences portfolio, competing broadly with snapIoT while offering substantially greater scale, integration, and installed customer base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
snapIoT social profiles
Digital presencesnapIoT financial estimates
Financial estimateRevenue estimate
Valuation estimate
snapIoT leadership team
Management profileNumber of profiles
Profiles1 record
snapIoT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
snapIoT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about snapIoT
What does snapIoT do?
snapIoT is a clinical platform designed to create, launch, and manage clinical trials. The company provides a software platform for organizations conducting clinical research and drug development, supporting workflows associated with the design, initiation, and operational management of clinical studies.
Is snapIoT a public or private company?
snapIoT is a public company. It is classified as founder individual operated bootstrapped and is currently operating.
When was snapIoT founded?
snapIoT was founded in 2016. It employs 11 to 50 people.
Where is snapIoT based?
snapIoT is headquartered in San Diego, United States, in the North America region.
Who are snapIoT's main competitors?
Direct peers on record are Medidata (Dassault Systèmes), Castor, Anju Software, ArisGlobal, Bio-Optronics, Signant Health, Veeva Systems, Clario and Calyx. Oracle Health Sciences (Clinical One) is listed as a broad incumbent.
Does snapIoT have an API?
No public API is recorded for snapIoT.
What industry is snapIoT in?
snapIoT's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 513210 and its SIC code is 7372.